Analgesic Efficacy of the Erector Spinae Plane Block Using Bupivacaine Versus Bupivacaine/Magnesium Sulphate in Patients Undergoing Lumbar Spine Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
Introduction: Severe postoperative pain following spine surgery is a significant cause of morbidity, extended length of facility stay, and marked opioid usage The analgesic regime for postoperative pain usually includes paracetamol,NSAIDs and opioids. The opioid epidemic as well as the opioid side effects2 (sedation,respiratory depression, constipation, delayed patient mobilization) has led perioperative physicians to find a way of decreasing the use of opioids. Increasing the use of regional anesthesia is one of the measures to this end. Ultrasound-guided erector spinae plane block (ESP) is a-- popular, interfascial regional technique that was initially described for the management of thoracic neuropathic pain . As the erector spinae fascia extends from the nuchal fascia cranially to the sacrum caudally, local anesthetic agents extend through several levels, and the block can be effective over a large area The ESP block provides effective postoperative analgesic effect for 24 hours in patients undergoing lumbar spinal surgery Magnesium sulfate (MGS) is a noncompetitive antagonist of N-methyl, D-aspartate (NMDA) receptors with an analgesic effect and is essential for release of acetylcholine from the presynaptic terminals and, similar to calcium channel blockers (CCB), can prevent the entry of calcium into the cell It is suggested that magnesium has many important roles to play in nociception
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable postoperative-pain
Started Jul 2020
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedStudy Start
First participant enrolled
July 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2020
CompletedJuly 17, 2020
July 1, 2020
5 months
June 11, 2020
July 16, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
time to first request of analgesics in hours
time to first request of analgesics by the pateint in hours
change from base line for 24 hours
Study Arms (2)
Group (B)
ACTIVE COMPARATORwill receive The bilateral ESP blocks before surgery
Group B MG
ACTIVE COMPARATORwill receive bilateral ESP blocks performed by each side) before surgery
Interventions
Group (B) (n=15): will receive The bilateral ESP blocks were performed by injecting 40 mL of 0.25% bupivacaine (20 mL into each side) into the fascial plane between the deep surface of the erector spinae muscle and the transverse processes of the lumbar vertebrae
Eligibility Criteria
You may qualify if:
- orthopedic
- neurological patients
- undergoing posterior lumbar spine fusion
- American Society of Anesthesiologists (ASA) physical status 1 or 2.
You may not qualify if:
- Contraindications for regional blocks
- allergic reaction to drugs.
- Patients with a history of liver, renal, heart and vascular failure, cardiac conduction disturbance.
- opium addiction, any drug or substance abuse and chronic treatment with opium, non-steroidal anti-inflammatory drugs and calcium channel blockers (CCB).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Banī Suwayf, Egypt, 11391
Banī Suwayf, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor Doaa Rashwan
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 16, 2020
Study Start
July 18, 2020
Primary Completion
December 10, 2020
Study Completion
December 10, 2020
Last Updated
July 17, 2020
Record last verified: 2020-07